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Abstract: COVID-19 infection rates and severity are worse in marginalised groups, although, for
sexual and gender minorities, there are no data on infections, hospitalisations or deaths, but there
may be worse rates. This study uses information from Understanding Society: The UK Household
Longitudinal Study (UKHLS) to derive COVID-19 symptoms and positive tests by sexual orientation.
Data came from all seven UKHLS COVID-19 survey waves in 2020 and 2021, and sexual orientation
in main UKHLS waves 3 and 9. Numbers ranged from 17,800 to 12,000. Covariates in the regression
models were gender, age, highest educational qualification, ethnicity, diagnosed medical condition,
and key worker status. Compared to heterosexual individuals, more sexual minorities experienced
symptoms, and bisexual individuals reported a greater number of symptoms. Gays and lesbians
were no more or less likely to have been tested, but a larger proportion of bisexual individuals were
tested. Regression models showed that differences mostly disappeared when other characteristics
were considered. A small sample size means that principal questions remain, so health inequalities
have been largely unnoticed and therefore not addressed. Suitable action should be taken to minimise
their future risks. Why sexual and gender minorities have been omitted needs to be explored, and
action needs to be taken to ensure this does not happen again.
Keywords: sexual orientation; COVID-19; UKHLS; longitudinal study; health inequalities
1. Introduction
COVID-19 infection rates and severity have been worse in many societal groups who
already face disadvantage and discrimination, particularly in people who have socioeco-
nomic deprivation, who are from Black and minority ethnic backgrounds, and who are
older people. The pandemic has exacerbated existing health inequalities [1,2], but there is
a noticeable lack of information on sexual and gender minorities in these reports. Sexual
minority status can be recorded through identity (lesbian, gay, bisexual), sexual behaviour
(men who have sex with men (MSM), women who have sex with women (WSW), etc., or
by cohabitation, civil partnership, or same-sex marriage). Gender minority status can be
recorded through the presence of gender recognition certificates (but only around 12% of
trans people have these) [3], or a self-report of whether their current gender is the same as
that assigned at birth.
In sexual and gender minorities, the COVID-19 pandemic has worsened mental
health and wellbeing, health behaviours, safety, social connectedness, and access to routine
healthcare [4]. However, nothing has been published so far on the rates of infection,
symptom severity, hospitalisations, intensive care unit admissions, or deaths from COVID-
19 in UK sexual and gender minority populations. There are several reasons why there
might be differential rates. For gay and bisexual men, there was an increased risk of having
contact with a romantic/sexual partner outside of their household during the first UK
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lockdown [5], which may result in higher rates of COVID-19 infections. There are also
higher rates of ill mental health [6], poorer wellbeing [7], and smoking [8] compared to
heterosexual men. For lesbians and bisexual women, there are higher rates of obesity [9],
asthma [10], and smoking [8]. In trans women, there are higher rates of mental ill health
and poor wellbeing [11]. There is also a relatively higher proportion of sex workers [12].
In gay men and trans women, there is also a relatively high proportion of HIV/AIDS
infection [13].
Despite these risk factors for increased COVID-19 infections, hospitalisations, and
potential deaths, there is a lack of information on these rates amongst the UK LGBT
population. There are several datasets that could be used to address this lack of data, but
there are many issues that have thus far prevented this from taking place. The UK Office for
National Statistics (ONS) has stated that it is “currently unable to report on deaths registered
in England and Wales, including deaths involving COVID-19 by sexuality” (personal
communication, Professor Sir Ian Diamond, Chief Statistician, ONS, 23 February 2021).
Part of the reason for this is that sexual orientation and gender identity are not recorded
in death certification, and partly because the UK Census 2011 did not include questions
on sexual orientation and gender identity. The ONS COVID infection study does not ask
questions relating to gender identify or sexual orientation. The Hospital Episode Statistics
database also does not have sexual orientation or gender identity. The NHS Data Standard
for Sexual Orientation Monitoring was adopted in 2019, but coverage is still very poor,
possibly because “there is no need to collect data from every patient” [14]. There is no
equivalent for gender identity yet.
UK datasets that do include sexual orientation include the ONS Annual Population
Survey (APS), Health Survey for England (HSE), the Improving Access to Psychological
Therapies (IAPT) cohort study, and the English General Practice Patient Survey (GPPS),
but none of these have COVID-19 data. The Biobank cohort study has sexual behaviour
data, but not sexual orientation. The ONS also holds data on civil partnerships and
same-sex marriages, but this is a subset of around 15% of the minority sexual orientation
population [3]. Understanding Society: The UK Household Longitudinal Study (UKHLS)
records both COVID-19 data and sexual orientation, but the sample size is relatively small.
Datasets can be linked to the NHS database (Hospital Episode Statistics) to derive
hospitalisations and deaths, as long as each of the linking databases have suitable identifiers,
but linking datasets is statistically more complex than using a single database. It would be
possible to link the APS, HSE, or IAPT databases this way, but not the GPPS. It would also
be possible to link the Biobank or the partnerships data. None of these linkage projects
have been done due to lack of staff time and other priorities of the ONS team (personal
communication, J Tinsley, Head of Data, Health Analysis and Life Events Division, Public
Policy Analysis, ONS; 9 June 2021).
The NHS workforce database also records sexual orientation as well as COVID-19 data,
and, as the NHS employs around 1.5 million people [15], even though sexual orientation
coverage may not be high, this could also be a very good source of data.
Large datasets that include gender identity are far fewer, and it is hoped that the
addition of both sexual orientation and gender identity questions in the UK Census 2021
will help to alleviate this lack of data.
This study uses information from the UKHLS to derive the first information available
on the rates of COVID-19 symptoms and positive COVID-19 tests, as well as other related
information, by sexual orientation identity in the UK population.
2. Materials and Methods
2.1. Data and Materials
Sample: The data come from all seven waves of the UKHLS COVID-19 surveys [16,17].
These surveys were collected via the Web in April, May, June, July, September, and Novem-
ber 2020, as well as January 2021. Respondents to the COVID-19 surveys were respondents
to wave 9 of the UKHLS, 2017–2019. The UKHLS has interviewed all adult household
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members from the sample annually since 2009. These COVID-19 surveys cover a variety
of topics, including COVID-19 symptoms, testing, hospitalisation, childcare, key working
status, furlough, mental health, and health behaviours. Approximately 17,800 individuals
completed the April 2020 survey, and the number of responses decreased to just under
12,000 by January 2021.
2.2. Variables
Sexual Orientation: The UKHLS asked individuals about their sexual orientation in the
main survey, as well as waves 3 (2011–2013) and 9 (2017–2019) of the survey. One standard
question was used to assess sexual orientation, and responses included ‘heterosexual or
straight’ (reference group), ‘gay or lesbian’, ‘bisexual’, ‘other’, and ‘prefer not to say’. We
took information from both waves 3 and 9. If responses were not consistent, then the
latest response was taken. Individuals who identified as ‘other’ or ‘prefer not to say’ were
dropped from this analysis.
COVID-19 Symptoms, Testing, and Hospitalisation: At each month of the COVID-19
surveys, individuals were asked if they had experienced any COVID-19 symptoms, had
been tested, or had been hospitalised due to COVID. In the April 2020 survey, individuals
were asked if they had ever experienced symptoms, been tested, or were hospitalised,
while, in the following surveys, respondents were asked if any of these had happened since
the last COVID-19 survey. The reference group for these dichotomous variables was the
‘no’ response.
Covariates: The covariates included in the models were gender, age, highest educa-
tional qualification, ethnicity, diagnosed medical condition, and key worker status. Gender
was a dichotomous variable, with men as the reference group. Highest educational qualifi-
cation was a three-category variable. The responses were degree (i.e., university degree or
higher; reference), A-level, or other higher qualifications (i.e., A-levels = exams taken at
age 18 (year 13); other higher = teaching, nursing, or diploma certifications), and GCSE
or lower (i.e., GCSE: General Certificate of Secondary Education, exams taken at age 16
(year 11); lower qualifications: Certificate of Secondary Education, skills certifications,
apprenticeships, and clerical qualification). Ethnicity was a four-category variable, with
responses of White British (reference), Black African or Caribbean, Indian, Pakistani or
Bangladeshi, and other ethnicity. Diagnosed medical condition and key worker status were
dichotomous variables, with ‘no’ as the reference group. Individuals were asked if they had
ever been diagnosed with any of 17 possible chronic conditions. These included asthma,
arthritis, diabetes, cancer, depression, high blood pressure, etc. At the first COVID-19
survey, individuals were asked if they had ever been diagnosed, and at each subsequent
survey, they were asked if they had been diagnosed since their last completed survey. Key
workers were defined by the UK government, and included individuals who worked in
health and social care, education and childcare, key public services, local and national
government, food services, public safety and national security, transportation, and utilities,
communications, and financial services. Not all individuals who worked in these sectors
were considered key workers, however, individuals should have been aware of whether
they met the keyworker status requirements. Age was a continuous variable.
2.3. Statistics
COVID-19 symptoms, testing, and hospitalisation proportions were described by
sexual orientation. Logistic regression models were run to determine whether COVID-19
symptoms or testing differed by sexual orientation. Models were not run for hospitali-
sations due to small numbers amongst sexual minorities. Outcomes were pooled across
all months. Thus, the models tested if an individual had ever experienced COVID-19
symptoms or had been tested for COVID-19 at any month. Due to differences in report-
ing and experience of these outcomes by gender, interactions between sexual orientation
and gender were conducted. The results from two models are presented; the first model
includes all covariates, and the second model includes the gender and sexual orientation
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interaction term. Odds ratios are presented for the first model, and predicted probabilities
given for the second model.
3. Results
3.1. Nature of the Sample
Compared to heterosexual individuals, gays and lesbians were more likely to have
degrees, were less ethnically diverse, were younger, and were slightly more likely to have
a diagnosed medical condition or be keyworkers (Table 1). Similarly, bisexual individuals
were younger than heterosexual individuals, however, while a similar proportion had a
degree, more bisexual individuals had obtained A-levels. Additionally, bisexual individuals
were more ethnically diverse, were less likely to be a key worker, and were less likely
to have a diagnosed medical condition. These patterns were similar by gender, with the
exception of key workers. Lesbians were more likely to be key workers compared to either
heterosexual or bisexual women. Gay and bisexual men were no more or less likely to be
key workers compared to heterosexual men.
























Degree 5980 (28) 159 (49) 113 (28) 2172 (29) 74 (49) 36 (36) 1997 (27) 51 (51) 61 (26)
A-level or similar 5771 (34) 88 (31) 100 (46) 1995 (35) 47 (31) 24 (46) 2480 (34) 28 (32) 55 (49)
GCSE or lower 4695 (38) 50 (20) 55 (26) 1606 (36) 27 (21) 12 (18) 2918 (39) 17 (17) 34 (25)
Ethnicity
White BRITISH 14,619 (88) 293 (94) 223 (82) 5156 (87) 137 (93) 54 (80) 6926 (88) 96 (97) 128 (82)
Black African/Caribbean 454 (6) 2 (0) 2 (1) 110 (2) 1 (0) 0 (0) 234 (2) 1 (0) 2 (1)
Indian/Pakistani/Bangladeshi 1103 (4) 3 (0) 23 (5) 386 (5) 2 (1) 12 (13) 485 (4) 0 (0) 9 (1)
Other ethnicity 1090 (6) 25 (5) 40 (13) 346 (6) 18 (6) 11 (7) 564 (6) 23 (3) 23 (16)
Keyworker
No 11,851 (73) 201 (71) 200 (79) 4434 (76) 113 (78) 58 (80) 5178 (71) 54 (56) 111 (77)
Yes 4588 (27) 107 (29) 68 (21) 1306 (24) 38 (22) 16 (20) 2372 (29) 41 (44) 40 (23)
Diagnosed medical
condition
No 6938 (40) 113 (36) 128 (47) 2369 (42) 62 (37) 33 (48) (38) 32 (35) 77 (44)
Yes 10,462 (60) 211 (64) 165 (53) 3676 (58) 96 (64) 44 (52) 5026 (62) 69 (65) 87 (56)
Mean age 49.98 44.54 33.02 49.87 45.06 36.62 50.09 43.42 31.12
* Raw numbers and weighted percentages in parentheses; weighted means.
3.2. COVID-19 Results
The proportions of individuals who experienced COVID-19 symptoms, testing, or
hospitalisation differed by sexual orientation (Table 2). A larger proportion of sexual mi-
norities experienced symptoms compared to heterosexual individuals. While the number of
symptoms experienced was similar between heterosexual and gay or lesbian respondents,
bisexual individuals reported experiencing a greater number of symptoms. Similarly, gays
and lesbians were no more or less likely to report having been tested, however, a larger
proportion of bisexual individuals were tested. There was no apparent difference in the
proportion of individuals who had been hospitalised by sexual orientation. Again, there
were differences by gender. While bisexual men had similar proportions of individuals
who had experienced COVID-19 symptoms, a larger proportion of bisexual women had
experienced symptoms compared to either heterosexual women or lesbians. A larger
proportion of lesbian and bisexual women experienced five or more symptoms compared
to heterosexual women. While a larger proportion of gay men were hospitalised, a smaller
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proportion of lesbians were hospitalised compared to heterosexual men or women, respec-
tively. Conversely, a smaller proportion of bisexual men were hospitalized, while a larger
proportion of bisexual women were hospitalised compared to heterosexual men or women,
gay men, or lesbians.
Table 2. COVID-19 symptoms and testing amongst individuals by sexual orientation and gender *.



















Has had COVID symptoms
No 11,413 (80) 188 (75) 162 (64) 4954 (83) 110 (75) 54 (78) 6457 (79) 75 (75) 107 (61)
Yes 2897 (19) 72 (25) 81 (35) 1091 (17) 46 (25) 23 (22) 1806 (21) 26 (25) 57 (39)
Number of COVID symptoms
No symptoms 55 (2) 1 (0) 2 (2) 17 (1) 1 (0) 0 (0) 38 (2) 0 (0) 2 (4)
One symptom 215 (7) 1 (2) 4 (2) 84 (8) 1 (4) 2 (2) 131 (6) 0 (0) 2 (2)
Two symptoms 386 (10) 8 (14) 6 (4) 126 (11) 8 (21) 1 (1) 160 (9) 0 (0) 5 (5)
Three symptoms 379 (14) 10 (15) 5 (5) 178 (16) 6 (17) 3 (16) 201 (12) 4 (11) 2 (2)
Four symptoms 378(14) 8 (14) 5 (12) 151 (17) 5 (17) 1 (3) 227 (12) 3 (8) 3 (3)
Five or more symptoms 1584 (54) 44 (55) 59 (76) 536 (48) 25 (42) 16 (78) 1048 (59) 19 (81) 43 (85)
Tested for Coronavirus
No 10,044 (72) 165 (70) 162 (65) 4447 (76) 96 (68) 58 (82) 5596 (69) 69( 76) 103 (58)
Yes 4265 (28) 94 (30) 81 (35) 1597 (24) 62 (32) 19 (18) 2667 (31) 31 (24) 61 (42)
Hospitalised due to COVID
symptoms
No 13,675 (96) 250 (97) 229 (96) 5820 (97) 152 (97) 74 (99) 7853 (95) 97( 97) 153 (94)
Yes 604 (4) 10 (3) 11 (4) 216 (3) 6 (3) 2 (1) 388 (5) 4 (3) 9 (6)
* Raw numbers and weighted percentages in parentheses.
3.3. Regression Models
After adjusting for sociodemographic characteristics, gays, lesbians, and bisexual
individuals were no more or less likely to have experienced COVID-19 symptoms compared
to heterosexual individuals (Table 3). There were some differences by sociodemographic
characteristics. For example, women, those of other ethnicity, key workers, and those with
diagnosed medical conditions were more likely to have experienced symptoms. Individuals
with lower levels of education or who were older were less likely to have experienced any
symptoms. The inclusion of an interaction between sexual orientation and gender showed
that there were no significant differences in experiences of COVID-19 symptoms by sexual
orientation and gender.
Heterosexual females had a higher probability (23%) of having experienced COVID-19
symptoms than heterosexual males (18%). There was no statistical difference between gay
men and lesbians or between bisexual males and females (Table 4). Additionally, there
were no differences in the probability of having experienced COVID-19 symptoms among
males of different sexual orientations or among females of different sexual orientations.
For example, the probability of having experienced COVID-19 symptoms amongst females
was 23% for heterosexual individuals, 20% for lesbians, and 28% for bisexual individuals,
however, these were not significantly different. While some of these differences were
approaching significance, none were at the 0.05 level, which may have been due to the
sample sizes.
Similarly, there were no statistical differences in the likelihood of being tested for
COVID-19 between gays or lesbians, bisexual individuals, and heterosexual individuals
(Table 5). Similar to the symptoms model, women and key workers were more likely to
have been tested. Individuals with lower than degree education or who were of Indian,
Pakistani, or Bangladeshi ethnicity were less likely to have been tested.
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Table 3. Odds ratios of sexual orientation as a predictor for COVID-19 symptoms.
Sociodemographic Characteristics
Model 1
Odds Ratio 95% Confidence Interval
Sexual orientation (Ref = Heterosexual)
Gay/Lesbian 0.98 (0.65, 1.47)
Bisexual 1.62 (0.79, 3.33)
Gender (Ref = Male)
Female 1.25 (1.07, 1.47)
Age 0.98 (0.98, 0.99)
Educational attainment (Ref = Degree)
A-level or similar 0.75 (0.63, 0.89)
GCSE or lower 0.66 (0.53, 0.83)
Ethnicity (Ref = White British)
Black African/Caribbean 1.28 (0.72, 2.28)
Indian/Pakistani/Bangladeshi 0.82 (0.57, 1.16)
Other Ethnicity 1.66 (1.14, 2.42)
Keyworker (Ref = No)
Yes 1.53 (1.29, 1.82)
Ever diagnosed with medical condition (Ref = No)
Yes 1.18 (1.00, 1.39)
Table 4. Marginal probabilities of experiencing COVID-19 symptoms by sexual orientation and gender.
Sexual Orientation
Gender Heterosexual Gay/Lesbian Bisexual
Male 0.18 0.19 0.35
Female 0.23 0.20 0.28
Contrast between Gender *
* = Difference between males and females.
Table 5. Odds ratios of sexual orientation as a predictor for COVID-19 testing.
Sociodemographic Characteristics Model 1
Odds Ratio 95% Confidence Interval
Sexual orientation (Ref = Heterosexual)
Gay/Lesbian 0.93 (0.61, 1.41)
Bisexual 1.25 (0.60, 2.59)
Gender (Ref = Male)
Female 1.29 (1.13, 1.48)
Age 1.00 (0.99, 1.00)
Educational attainment (Ref = Degree)
A-level or similar 0.82 (0.71, 0.95)
GCSE or lower 0.78 (0.65, 0.94)
Ethnicity (Ref = White British)
Black African/Caribbean 0.73 (0.42, 1.27)
Indian/Pakistani/Bangladeshi 0.50 (0.45, 0.71)
Other Ethnicity 1.37 (0.97, 1.93)
Keyworker (Ref = No)
Yes 2.31 (1.99, 2.69)
Ever diagnosed with medical condition (Ref = No)
Yes 1.12 (0.98, 1.29)
Again, the interaction showed a difference in the probability of having been tested
between heterosexual males (28%) and females (35%, Table 6). However, there were
no statistical differences between males and females in either sexual minority group.
Additionally, within males or females, there were no statistical differences in the probability
of having been tested amongst sexual orientation groups. For example, the probability
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of having been tested was 28% for heterosexual males, 31% for gay males, and 36% for
bisexual males. Some differences did approach significance, suggesting that differences
may have been observed with larger sample sizes.
Table 6. Marginal probabilities of having been tested for COVID-19 by sexual orientation and gender.
Sexual Orientation
Gender Heterosexual Gay/Lesbian Bisexual
Male 0.28 0.31 0.36
Female 0.35 0.22 0.38
Contrast between Gender *
* = Difference between males and females.
4. Discussion
4.1. Statement of Principal Findings
This ground-breaking study has shown that there are differences in the proportions
of COVID-19 symptoms and likelihood of having a COVID-19 test by sexual orientation
groups, but these differences mostly disappear when other characteristics, such as employ-
ment and ethnicity, are taken into account. So, despite the differences in the rates of adverse
health behaviours and illnesses associated with higher rates of COVID-19 infections and
hospitalizations, no apparent differences between groups were found. It is unclear whether
this is due to the small sample sizes available in the UKHLS.
4.2. Strengths and Weaknesses of this Study
A major strength of this study is that it uses nationally representative data and that it
is able to compare directly COVID-19 and health characteristics between sexual orientation
groups without using data linkage. Linking population-based administrative information
from two or more databases is very useful in providing detailed individual information
from different sources for research purposes. In particular, it can answer questions requiring
large sample sizes or detailed data on populations, such as sexual minority or gender
minority status. However, there can be biases from linkage errors, or where records cannot
be linked or are linked incorrectly, reducing the accuracy of the results [18]. Using a single
database means no linkage errors, but is limited by the questions asked for that dataset.
In this situation, the results are also limited by small sample sizes, so the ability to pick
out small differences in COVID-19 symptoms and the probability of having a COVID-19
test will be unlikely. We were unable to analyse hospitalisation data due to the small
sample sizes.
Another limitation is that sexual orientation is determined by a single question and
does not take into account other aspects of sexual preference, such as behaviour or ideation.
Furthermore, while the assessment was conducted twice, changes in sexual orientation
were not included in the analysis, and only the last recorded sexual orientation was used.
Another limitation is that it was not possible to analyse by gender identity, as the UKLHS
does not include that attribute in the dataset. We chose not to include the ‘other’ and ‘prefer
not to say’ groups, as the sexual orientation identity of people responding thus is unclear.
4.3. Comparison with Other Studies and Discussing Important Differences in Results
To date, there have been no other estimates published in the world on the incidence,
hospitalization, or death rates in sexual and gender minority populations. A number of
countries have been calling for this data, for example, in the US, where it is known that
sexual minority individuals have a higher self-reported prevalence of several underlying
health conditions associated with severe outcomes from COVID-19 than do heterosexual
individuals [19].
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4.4. Meaning of the Study: Possible Explanations
This study can only give a small amount of information on COVID-19 incidence by
sexual orientation because of the small sample sizes available. However, one issue that can
be taken from this study is that the lack of data on COVID-19 in LGBT populations mirrors
the lack of health information by sexual orientation or gender identity in other conditions.
For example, there is no good UK data on cancer by sexual orientation or gender identity,
and sexual orientation was only added to the National Disease Registration Service (NDRS)
core dataset in 2018, becoming mandatory in 2020, but reporting has been delayed by
COVID-19 issues (personal communication, Andrew Murphy, Head of Cancer Datasets,
NDRS, PHE, July 2020). It is unclear when they will add gender identity to this dataset. It
has been thought that this lack of data is partly due to national policy discussions, which
frame LGBT issues within an “it’s getting better” narrative, so there is a failure to examine
what is actually happening [20].
The current UK Government Minister for Equalities stated that, “we have not found
that LGBT groups specifically have been disproportionately affected” [21]. She has con-
flated a lack of data with the assumption of no effect. This lack of enquiry suggests an
unwillingness to adequately acknowledge that there may well be health inequalities, and
that efforts should be made to find and address them.
4.5. Implications for Clinicians, UK and International Policymakers, and Patients
Institutional homophobia is a relatively new concept, similar to institutional racism,
and has been defined as: “The collective failure of an organisation to provide an appropriate
and professional service to people because of their sexuality. It can be detected in processes,
attitudes and behaviour which amount to discrimination through unwitting prejudice,
ignorance, thoughtlessness and stereotyping” [22].
Official data collection that omits sexual orientation and gender identity is a subtle
form of institutional homophobia/transphobia. The message appears to be that if these
factors are not counted, populations with these attributes are not important. In 2017–2018,
the UK government made great strides in promoting LGBT issues through their LGBT
Action Plan [23], which included the development and uptake of sexual orientation and
trans status monitoring in healthcare, as well as the recruitment of the UK’s first LGBT
Health Advisor. Unfortunately, the Action Plan initiative, which would have delivered
major advances, is no longer promoted by the current UK government [24].
4.6. Unanswered Questions and Future Research
It is known that men are more at risk of intensive care unit hospitalisations and deaths
than women [25], despite equal infection rates from COVID-19. However, it is unclear why
this is happening. Many theories have been suggested around lifestyle, access to healthcare,
prevalence of pre-existing conditions, and physiological differences, such as prevalence of
ACE2 receptors, sex hormone milieu, differential immune system strengths, and factors
associated with the X chromosome [26]. Investigating the relative rates of COVID-19
hospitalisations and deaths in trans men and trans women may help to provide further
evidence for some of these factors. Lesbians may have higher testosterone levels [27], and
it is unclear if this is associated with better or worse COVID-19 outcomes, including long
COVID syndrome.
Although we have not been able to show higher infection rates in gay men from this
study, which would have been expected from the data from the National Survey of Sexual
attitudes and Lifestyles (NATSAL) study [5] mentioned previously, the small sample size
in the UKHLS means that the principal questions remain around infection rates, symptom
severity, hospitalisations, intensive care unit admissions, and deaths from COVID-19 in UK
sexual and gender minority populations. These should be supplied as soon as possible by
whatever means available to researchers, so that suitable action can be taken as necessary
to minimise future risks to people within the sexual and gender minority communities.
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Finally, the reasons why sexual and gender minorities have been omitted from all of
the major data collection activities in the UK on COVID-19 needs to be explored, and action
needs to be taken to ensure that this does not happen in the future.
5. Conclusions
There are a number of reasons why incidence, hospitalisations, and death rates from
COVID-19 in sexual and gender minorities might be higher than in the majority population.
This study uses information from the UKHLS to derive the first information available
on the rates of COVID-19 symptoms and positive COVID-19 tests by sexual orientation
identity in the UK population. The proportions of gay/lesbian and particularly bisexual
individuals reporting COVID-19 symptoms and taking COVID-19 tests was higher than
heterosexual individuals, but most of the results were not statistically significant in the
regression models that took other characteristics into account, probably because of small
sample sizes. Future studies must ensure better representation of minority group data.
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